Here, the authors describe the history of the efforts to expand knowledge of Wilms tumour biology, genetics, embryonal origin and associated syndromic and familial conditions, and to clinically apply prognostic biomarkers and development of preclinical models.
- Daniela Perotti
- Richard D. Williams
- Kathy Pritchard-Jones